VERTEX PHARMACEUTICALS INC / MA Payments for (Proceeds from) Other Investing Activities
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Payments for (Proceeds from) Other Investing Activities of $1.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was $1.70M, a 60.47% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was $15.90M, a 48.54% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was -$800.00K, a 109.88% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for fiscal 2025 was $24.70M, a 54.26% decline from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for fiscal 2024 was $54.00M, a 74.19% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for fiscal 2023 was $31.00M, a 35.15% decline from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA payments for (proceeds from) other investing activities for fiscal 2022 was $47.80M.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 3 month as first filed | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 9 month as first filed | Payments for (Proceeds from) Other Investing Activities 12 month | Payments for (Proceeds from) Other Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.70M 10-Q · filed 2026-08-04 | $17.60M derived: sum of 3 quarters · filed 2026-08-04 | $16.80M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $15.90M derived: sum of 2 quarters · filed 2026-05-05 | $15.10M derived: sum of 3 quarters · filed 2026-05-05 | $19.40M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $15.10M derived: sum of 2 quarters · filed 2026-02-13 | $19.40M derived: sum of 3 quarters · filed 2026-08-04 | $24.70M 10-K · filed 2026-02-13 | |||
| 2025-09-30 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.50M derived: sum of 2 quarters · filed 2026-08-04 | $8.80M 10-Q · filed 2025-11-04 | $39.70M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $9.60M 10-Q · filed 2026-08-04 | $40.50M derived: sum of 3 quarters · filed 2026-08-04 | $48.60M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $5.30M 10-Q · filed 2026-05-05 | $36.20M derived: sum of 2 quarters · filed 2026-05-05 | $44.30M derived: sum of 3 quarters · filed 2026-05-05 | $59.30M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $30.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $39.00M derived: sum of 2 quarters · filed 2026-02-13 | $54.00M derived: sum of 3 quarters · filed 2026-02-13 | $54.00M 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $23.10M derived: sum of 2 quarters · filed 2025-11-04 | $23.10M 10-Q · filed 2025-11-04 | $23.10M derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2024-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $15.00M 10-Q · filed 2025-08-05 | $15.00M derived: sum of 3 quarters · filed 2026-02-13 | $16.10M derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $1.10M derived: sum of 3 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.10M derived: sum of 2 quarters · filed 2026-02-13 | $31.00M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $31.00M 10-Q · filed 2024-11-05 | |||||
| 2023-06-30 | $29.90M 10-Q · filed 2024-08-02 | ||||||
| 2022-12-31 | $47.80M 10-K · filed 2025-02-13 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2020-02-13 | ||||||
| 2018-12-31 | -$75.00K 10-K · filed 2020-02-13 | ||||||
| 2017-12-31 | -$681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$673.00K derived: sum of 2 quarters · filed 2020-02-13 | -$1.00M derived: sum of 3 quarters · filed 2020-02-13 | -$1.06M 10-K · filed 2020-02-13 | -$436.00K 10-K · filed 2018-02-15 | ||
| 2017-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | -$320.00K derived: sum of 2 quarters · filed 2017-10-30 | -$380.00K 10-Q · filed 2017-10-30 | -$412.00K derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-06-30 | -$328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$388.00K 10-Q · filed 2017-07-28 | -$420.00K derived: sum of 3 quarters · filed 2019-02-13 | -$486.00K derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-03-31 | -$60.00K 10-Q · filed 2017-04-28 | -$92.00K derived: sum of 2 quarters · filed 2019-02-13 | -$158.00K derived: sum of 3 quarters · filed 2019-02-13 | $81.00K derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$98.00K derived: sum of 2 quarters · filed 2019-02-13 | $141.00K derived: sum of 3 quarters · filed 2019-02-13 | $61.00K 10-K · filed 2019-02-13 | $7.00K 10-K · filed 2017-02-23 | ||
| 2016-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $173.00K derived: sum of 2 quarters · filed 2017-10-30 | $93.00K 10-Q · filed 2017-10-30 | $90.00K 10-Q · filed 2016-10-31 | $21.04M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $159.00K 10-Q · filed 2017-07-28 | $21.11M derived: sum of 3 quarters · filed 2018-02-15 | $22.18M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-03-31 | -$80.00K 10-Q · filed 2017-04-28 | -$83.00K 10-Q · filed 2016-05-03 | $20.87M derived: sum of 2 quarters · filed 2018-02-15 | $21.94M derived: sum of 3 quarters · filed 2018-02-15 | $22.65M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2015-12-31 | $20.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $22.02M derived: sum of 2 quarters · filed 2018-02-15 | $22.73M derived: sum of 3 quarters · filed 2018-02-15 | $21.93M 10-K · filed 2018-02-15 | -$52.00K 10-K · filed 2016-02-16 | ||
| 2015-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $1.78M derived: sum of 2 quarters · filed 2016-10-31 | $982.00K 10-Q · filed 2016-10-31 | $1.13M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | $712.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | -$87.00K 10-Q · filed 2016-08-01 | $65.00K derived: sum of 3 quarters · filed 2017-02-23 | -$371.00K derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | -$799.00K 10-Q · filed 2016-05-03 | -$647.00K derived: sum of 2 quarters · filed 2017-02-23 | -$1.08M derived: sum of 3 quarters · filed 2017-02-23 | -$1.03M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$284.00K derived: sum of 2 quarters · filed 2017-02-23 | -$232.00K derived: sum of 3 quarters · filed 2017-02-23 | $244.00K 10-K · filed 2017-02-23 | |||
| 2014-09-30 | -$436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$384.00K derived: sum of 2 quarters · filed 2015-10-30 | $92.00K 10-Q · filed 2015-10-30 | ||||
| 2014-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $528.00K 10-Q · filed 2015-08-04 | |||||
| 2014-03-31 | $476.00K 10-Q · filed 2015-05-04 | ||||||
| 2013-12-31 | -$1.70M 10-K · filed 2016-02-16 | ||||||
| 2013-03-31 | -$472.00K 10-Q · filed 2013-05-08 | -$643.00K derived: sum of 2 quarters · filed 2015-02-13 | -$131.00K derived: sum of 3 quarters · filed 2015-02-13 | $138.00K derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | -$171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $341.00K derived: sum of 2 quarters · filed 2015-02-13 | $610.00K derived: sum of 3 quarters · filed 2015-02-13 | $826.00K 10-K · filed 2015-02-13 | |||
| 2012-09-30 | $512.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $781.00K derived: sum of 2 quarters · filed 2012-11-06 | $997.00K 10-Q · filed 2012-11-06 | $635.00K derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $485.00K 10-Q · filed 2012-08-08 | $123.00K derived: sum of 3 quarters · filed 2014-02-11 | $318.00K derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-03-31 | $216.00K 10-Q · filed 2013-05-08 | -$146.00K derived: sum of 2 quarters · filed 2014-02-11 | $49.00K derived: sum of 3 quarters · filed 2014-02-11 | -$144.00K derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2011-12-31 | -$362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | -$167.00K derived: sum of 2 quarters · filed 2014-02-11 | -$360.00K derived: sum of 3 quarters · filed 2014-02-11 | $183.00K 10-K · filed 2014-02-11 | |||
| 2011-09-30 | $195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $2.00K derived: sum of 2 quarters · filed 2012-11-06 | $545.00K 10-Q · filed 2012-11-06 | $638.00K derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-06-30 | -$193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $350.00K 10-Q · filed 2012-08-08 | $443.00K derived: sum of 3 quarters · filed 2013-03-01 | $399.00K derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-03-31 | $543.00K 10-Q · filed 2012-05-10 | $636.00K derived: sum of 2 quarters · filed 2013-03-01 | $592.00K derived: sum of 3 quarters · filed 2013-03-01 | $1.12M derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2010-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $49.00K derived: sum of 2 quarters · filed 2013-03-01 | $575.00K derived: sum of 3 quarters · filed 2013-03-01 | $955.00K 10-K · filed 2013-03-01 | |||
| 2010-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $482.00K derived: sum of 2 quarters · filed 2011-11-03 | $862.00K 10-Q · filed 2011-11-03 | $150.00K derived: sum of 4 quarters · filed 2012-02-22 | |||
| 2010-06-30 | $526.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $906.00K 10-Q · filed 2011-08-09 | $194.00K derived: sum of 3 quarters · filed 2012-02-22 | $592.00K derived: sum of 4 quarters · filed 2012-02-22 | |||
| 2010-03-31 | $380.00K 10-Q · filed 2011-05-06 | -$332.00K derived: sum of 2 quarters · filed 2012-02-22 | $66.00K derived: sum of 3 quarters · filed 2012-02-22 | -$127.00K derived: sum of 4 quarters · filed 2012-02-22 | |||
| 2009-12-31 | -$712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$314.00K derived: sum of 2 quarters · filed 2012-02-22 | -$507.00K derived: sum of 3 quarters · filed 2012-02-22 | -$679.00K 10-K · filed 2012-02-22 | |||
| 2009-09-30 | $398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $205.00K derived: sum of 2 quarters · filed 2010-10-28 | $33.00K 10-Q · filed 2010-10-28 | ||||
| 2009-06-30 | -$193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | -$365.00K 10-Q · filed 2010-08-03 | |||||
| 2009-03-31 | -$172.00K 10-Q · filed 2010-05-03 | ||||||
| 2008-12-31 | $696.00K 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |